The Wearables Guide: What to Track, What to Ignore, and How to Choose
The consumer health wearable market has exploded — Oura Ring, Whoop, Garmin, Apple Watch, Continuous Glucose Monitors, smart scales, and dozens of other devices all promise to transform health through data. The reality: some of this data is genuinely valuable; some is noise marketed as signal; and some devices provide information that, without the right interpretive framework, can worsen rather than improve health decisions.
- The highest-value wearable data for longevity is: overnight HRV (autonomic nervous system balance, recovery quality), resting heart rate trends (cardiovascular fitness trajectory), sleep consistency (total sleep time and wake time regularity), daily step count and activity level, and blood oxygen saturation (SpO2) for sleep apnea screening. These metrics are reasonably accurate and directly actionable.
- The lowest-value wearable data (despite high marketing prominence): calorie expenditure estimates (typically 20-40 percent inaccurate), sleep stage classification (50-70 percent accuracy for deep sleep), and stress scores derived from HRV algorithms (useful as trend indicators, not absolute measures). Do not make specific behavioral changes based on single-day values of these metrics.
- The CGM (continuous glucose monitor) represents the highest clinical value wearable for metabolic phenotyping — providing information about postprandial glucose responses, food order effects, exercise timing effects, and sleep-glucose relationships that no other available consumer device can capture. Two to four weeks of CGM use provides more metabolic insight than years of standard bloodwork.
- Choosing a wearable: prioritize battery life (daily charging interrupts sleep monitoring consistency), sensor accuracy validation (published peer-reviewed validation against clinical gold standards), and whether the device measures what you actually want to track. Oura Ring and Whoop have the most published academic validation for sleep metrics; Garmin and Apple Watch for activity and VO2 max estimation.
- The data without action is not valuable. The most important wearable habit is weekly review of trends — not daily checking of scores. A 4-week average HRV trend, a monthly resting heart rate trajectory, and a weekly sleep consistency score are more actionable than daily fluctuations that primarily reflect normal biological variation.
Consumer health wearables have fundamentally changed what is possible in personal health monitoring. For the first time, individuals can track continuous physiological data — heart rate variability, sleep staging, blood oxygen, activity, and in some devices glucose — outside of clinical settings, across days and weeks, in the context of real life. This is genuinely transformative for longevity medicine. It is also generating a new category of health anxiety driven by imprecise metrics, and a market that is not uniformly incentivized to accurately represent what its devices can and cannot measure.1
What Wearables Measure Well
Resting heart rate: Accurately measured from optical HR sensors, and one of the most reliable longevity biomarkers available. Declining resting heart rate over months of aerobic training is one of the clearest indicators of improving cardiovascular fitness. A resting heart rate consistently below 60 BPM reflects high parasympathetic tone and cardiorespiratory fitness. Heart rate variability (RMSSD): Reasonably accurate from good-quality optical sensors measured overnight. The most valuable wearable metric for recovery monitoring and autonomic nervous system health — see article 1.10 for full interpretation guidance. Sleep/wake detection: Approximately 90-95 percent accurate. Reliable for determining total sleep time and sleep/wake timing consistency. Step count and activity: Highly accurate from accelerometers. Daily step counts and activity minutes are reliable and directly actionable metrics with strong epidemiological longevity associations.2
What Wearables Measure Poorly
Sleep staging (deep sleep, REM): As covered in article 5.6, consumer devices have 50-70 percent sensitivity for SWS and 70-80 percent for REM versus polysomnography gold standard. Individual night deep sleep values are unreliable. Weekly averages are more stable. Calorie expenditure: Studies consistently find 20 to 40 percent errors in caloric expenditure estimation from wrist-based wearables — sufficient to mislead dietary decision-making. Do not eat according to wearable calorie estimates. Stress scores: Composite stress algorithms from HRV and accelerometry are directionally useful for trend identification but not precise enough for day-to-day behavioral decisions. Blood glucose (non-invasive): No current consumer wearable accurately measures blood glucose from the wrist or similar optical approaches; all consumer glucose monitoring still requires a subcutaneous sensor (CGM).
The CGM: A Tier Above Other Wearables
Among all consumer health monitoring devices, the CGM stands alone in clinical utility — because it provides genuinely novel information that cannot be obtained from any other consumer-accessible source. As covered in article 1.5, 14 days of CGM use provides more metabolic phenotyping information than years of standard annual bloodwork. Food order effects, post-meal glucose responses, sleep quality effects on fasting glucose, and exercise timing effects are all invisible to standard bloodwork and fully visible to CGM. It is the most clinically impactful consumer monitoring tool available for adults concerned about metabolic health.3
References
- 1Piwek L, et al. "The rise of consumer health wearables: promises and barriers." PLoS Medicine. 2016;13(2):e1001953.
- 2Shcherbina A, et al. "Accuracy in wrist-worn, sensor-based measurements of heart rate and energy expenditure in a diverse cohort." Journal of Personalized Medicine. 2017;7(2):3.
- 3Zeevi D, et al. "Personalized nutrition by prediction of glycemic responses." Cell. 2015;163(5):1079-1094.